BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24879845)

  • 1. Expression of hepatic drug-metabolizing cytochrome p450 enzymes and their intercorrelations: a meta-analysis.
    Achour B; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2014 Aug; 42(8):1349-56. PubMed ID: 24879845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics.
    Achour B; Russell MR; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2014 Apr; 42(4):500-10. PubMed ID: 24408517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes.
    Fang J; McKay G; Song J; Remillrd A; Li X; Midha K
    Drug Metab Dispos; 2001 Dec; 29(12):1638-43. PubMed ID: 11717183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of drug-metabolizing capacity by cytochrome P450 genotyping and expression.
    Temesvári M; Kóbori L; Paulik J; Sárváry E; Belic A; Monostory K
    J Pharmacol Exp Ther; 2012 Apr; 341(1):294-305. PubMed ID: 22262920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reevaluation of the microsomal metabolism of montelukast: major contribution by CYP2C8 at clinically relevant concentrations.
    Filppula AM; Laitila J; Neuvonen PJ; Backman JT
    Drug Metab Dispos; 2011 May; 39(5):904-11. PubMed ID: 21289076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 Pig liver pie: determination of individual cytochrome P450 isoform contents in microsomes from two pig livers using liquid chromatography in conjunction with mass spectrometry [corrected].
    Achour B; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2011 Nov; 39(11):2130-4. PubMed ID: 21795467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.
    Arbus C; Benyamina A; Llorca PM; Baylé F; Bromet N; Massiere F; Garay RP; Hameg A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):357-66. PubMed ID: 17951033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abundance and Associated Variations of Cytochrome P450 Drug-Metabolizing Enzymes in the Liver of East Asian Adults: A Meta-Analysis.
    An XX; Yu Y; Li GF; Yu G
    Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):225-233. PubMed ID: 33368014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
    Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
    Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of drug-drug interactions caused by human pregnane X receptor-mediated induction of CYP3A4 and CYP2C subfamilies in chimeric mice with a humanized liver.
    Hasegawa M; Tahara H; Inoue R; Kakuni M; Tateno C; Ushiki J
    Drug Metab Dispos; 2012 Mar; 40(3):474-80. PubMed ID: 22126990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Proteomic Analysis of Human Liver Microsomes: Rapid Characterization and Quantification of Hepatic Drug-Metabolizing Enzymes.
    Achour B; Al Feteisi H; Lanucara F; Rostami-Hodjegan A; Barber J
    Drug Metab Dispos; 2017 Jun; 45(6):666-675. PubMed ID: 28373266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of human CYP2C8 and CYP2C9 variants in pioglitazone metabolism in vitro.
    Muschler E; Lal J; Jetter A; Rattay A; Zanger U; Zadoyan G; Fuhr U; Kirchheiner J
    Basic Clin Pharmacol Toxicol; 2009 Dec; 105(6):374-9. PubMed ID: 19614891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
    Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
    Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
    Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein expression of various hepatic uridine 5'-diphosphate glucuronosyltransferase (UGT) enzymes and their inter-correlations: a meta-analysis.
    Achour B; Rostami-Hodjegan A; Barber J
    Biopharm Drug Dispos; 2014 Sep; 35(6):353-61. PubMed ID: 24931139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s.
    Prueksaritanont T; Gorham LM; Ma B; Liu L; Yu X; Zhao JJ; Slaughter DE; Arison BH; Vyas KP
    Drug Metab Dispos; 1997 Oct; 25(10):1191-9. PubMed ID: 9321523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.
    Ohtsuki S; Schaefer O; Kawakami H; Inoue T; Liehner S; Saito A; Ishiguro N; Kishimoto W; Ludwig-Schwellinger E; Ebner T; Terasaki T
    Drug Metab Dispos; 2012 Jan; 40(1):83-92. PubMed ID: 21994437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of benidipine and its enantiomers' metabolism by human liver cytochrome P450 enzymes.
    Yoon YJ; Kim KB; Kim H; Seo KA; Kim HS; Cha IJ; Kim EY; Liu KH; Shin JG
    Drug Metab Dispos; 2007 Sep; 35(9):1518-24. PubMed ID: 17537876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
    Kitamura A; Mizuno Y; Natsui K; Yabuki M; Komuro S; Kanamaru H
    Biopharm Drug Dispos; 2005 Mar; 26(2):59-65. PubMed ID: 15619261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.